Synvisc One Injecion - Hylan G-F 20, 6ml

Synvisc One Injection – Hylan G-F 20, 6ml

£265.47

Compare
SKU: 3336625 Category:
Synvisc

Description

Synvisc One Injection – Hylan G-F 20, 6ml

Introducing Synvisc One Injection – Hylan G-F 20:

Revitalize your joints and reclaim your mobility with Synvisc One Injection – Hylan G-F 20. This innovative solution is designed to provide long-lasting relief from joint pain and discomfort, allowing you to enjoy a more active and fulfilling life.

Synvisc One Injection – Hylan G-F 20 is a trusted and approved treatment for osteoarthritis, a common condition characterized by the degeneration of joint cartilage. With its unique formulation of hyaluronan, a naturally occurring lubricating substance found in healthy joints, this injection helps replenish the depleted synovial fluid and restore the cushioning effect within the joint.

Using the power of advanced medical science, Synvisc One Injection – Hylan G-F 20 offers several benefits:

  1. Effective Pain Relief: Say goodbye to persistent joint pain and discomfort. Synvisc One Injection – Hylan G-F 20 provides significant and sustained pain relief, allowing you to engage in daily activities with greater ease.
  2. Improved Joint Function: Experience enhanced joint function and increased range of motion. Synvisc One Injection – Hylan G-F 20 helps restore the lubrication and cushioning properties of the synovial fluid, reducing friction and supporting smooth joint movement.
  3. Long-Lasting Results: Unlike temporary solutions, Synvisc One Injection – Hylan G-F 20 offers lasting relief. With a single injection, you can enjoy the benefits for up to six months, minimizing the need for frequent treatments.
  4. Minimally Invasive: The injection procedure is simple and minimally invasive, ensuring a comfortable experience for patients. Your healthcare professional can administer the injection in a clinic setting, allowing you to resume your daily routine quickly.
  5. Proven Safety Profile: Synvisc One Injection – Hylan G-F 20 has undergone rigorous clinical trials and is backed by extensive research. It has demonstrated a strong safety profile, making it a reliable choice for managing osteoarthritis symptoms.

Don’t let joint pain hold you back any longer. Take control of your mobility with Synvisc One Injection – Hylan G-F 20. Rediscover the joy of movement and embrace an active lifestyle once again. Order now and experience the difference firsthand!

Synvisc One Reviews

After using Synvisc One, it’s helpful to let others know about your experience. Reviews of an item help other users know that medicines received have helped the condition it is claimed for, how well the treatment worked or any issues to be aware of. We invite our users to leave a review of both their treatment and of the service provided. Click on the reviews tab to see if there has been feedback on this item.

What is the price of  Synvisc One?

The price of  Synvisc One is £265.47

Where can you buy Synvisc One?

You can buy Synvisc One at Dock Pharmacy Essex UK, UK Online Pharmacy.

Can you buy Synvisc One Over the counter?

Synvisc One is available to buy over the counter. You do not need a prescription to buy Synvisc One but you might be asked some questions about your medical health when you add it to your basket.

Additional information

EAN 5099627983723

Brand

Synvisc

How To Use

How To Use

Synvisc-One is administered as a single intra-articular. Strict aseptic administration technique must be followed.

  • Using an 18- to 20-gauge needle, remove synovial fluid or effusion before injecting Synvisc-One.
  • Do not use the same syringe for removing synovial fluid and for injecting Synvisc-One; however the same 18- to 20-gauge needle should be used.
  • Twist the tip cap before pulling it off, as this will minimize product leakage.
  • To ensure a tight seal and prevent leakage during administration, secure the needle tightly while firmly holding the luer hub.

Precaution: Do not over tighten or apply excessive leverage when attaching the needle or removing the needle guard, as this may break the syringe tip.

  • Inject the full 6 mL in one knee only.

 

Delivery Options

Delivery options

All deliveries are subject to the availability of the product and product sale conditions been met.

Order & Collect
Free next-day collection from In-Store

UK Delivery

Standard Delivery within the UK £3.50 Delivery time 3-4 days
First Class Delivery within the UK £5.90 Delivery time 1-2 days
Priority Delivery within the UK £7.10. Next day delivery by 1pm. Order must be placed by 1pm. Priority delivery is only available Monday to Thursday.

Europe Delivery

Standard Delivery within EEC from £12.50 Delivery time up to 5 days depending on the local delivery service within your country.
Expedited Delivery within EEC £39.50 Delivery time 2 days. Delivery by DHL, UPS or TNT.

Rest of the World

Standard Delivery Rest of the World from £16.10 Delivery Time 10 – 15 Days
Expedited Delivery Rest of the World £55.09 Delivery 5 days. Delivery service by DHL, TNT or UPS

For more information see our Shipping Policy or view our Return policy.

Product Details

Product Information

CONTRAINDICATIONS

  • Do not administer to patients with known hypersensitivity (allergy) to hyaluronan (sodium hyaluronate) preparations.
  • Do not inject Synvisc-One in the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site.

WARNINGS

  • Do not concomitantly use disinfectants containing quaternary ammonium salts for skin preparation because hyaluronan can precipitate in their presence.
  • Do not inject Synvisc-One extra-articularly or into the synovial tissues and capsule.
  • Intravascular injections of Synvisc-One may cause systemic adverse events.

PRECAUTIONS

General

  • The safety and efficacy of Synvisc-One in locations other than the knee and for conditions other than osteoarthritis have not been established.
  • The safety and effectiveness of the use of Synvisc-One concomitantly with other intra-articular injectables have not been established.
  • Use caution when injecting Synvisc-One into patients who are allergic to avian proteins, feathers or egg products.
  • The safety and efficacy of Synvisc-One in severely inflamed knee joints have not been established.
  • Strict aseptic administration technique must be followed.
  • STERILE CONTENTS. The syringe is intended for single use. The contents of the syringe must be used immediately after its packaging is opened. Discard any unused Synvisc-One.
  • Do not use Synvisc-One if package is opened or damaged. Store in original packaging (protected from light) at room temperature below 86°F (30°C). DO NOT FREEZE.
  • Remove any synovial fluid or effusion before injecting Synvisc-One.
  • Synvisc-One should be used with caution when there is evidence of lymphatic or venous stasis in the leg to be injected.

Information for Patients

  • Provide patients with a copy of the Patient Labeling prior to use.
  • Mild to moderate pain, swelling and/or effusion of the injected knee have been reported in clinical trials that were related to intra-articular injection of Synvisc-One. These events were typically transient and usually resolved on their own or with conservative treatment.
  • As with any invasive joint procedure, it is recommended that the patient avoid strenuous activities (for example, high-impact sports such as soccer, tennis or jogging) or prolonged weight-bearing activities for approximately 48 hours following the intra-articular injection. The patient should consult his or her physician regarding the appropriate time to resume such activities.

Use in Specific Populations

  • Pregnancy: The safety and effectiveness of Synvisc-One have not been established in pregnant women.
  • Nursing mothers: It is not known if Synvisc-One is excreted in human milk. The safety and effectiveness of Synvisc-One have not been established in lactating women.
  • Pediatrics: The safety and effectiveness of Synvisc-One have not been established in pediatric patients. Pediatric patients are defined as patients ≤ 21 years of age.

 

Side Effects

Reported Device-Related Adverse Events

The most commonly reported adverse events associated with Synvisc-One are the following:

  • Arthralgia
  • Arthritis
  • Arthropathy
  • Injection site pain
  • Joint effusion

A complete list of the frequency and rate of adverse events identified in the clinical study are provided in the Safety section (Table 3).

Potential Adverse Events

The following adverse events are among those that may occur in association with intra-articular injections, including Synvisc-One

  • Arthralgia
  • Joint stiffness
  • Joint effusion
  • Joint swelling
  • Joint warmth
  • Injection site pain
  • Arthritis
  • Arthropathy
  • Gait disturbance

A complete list of the frequency and rate of adverse events identified in the clinical study are provided in the Safety section (Table 2).

Post-marketing Experience

SYNVISC® (3-injection regimen) post-marketing experience has identified the following systemic events to occur rarely with administration: rash, hives, itching, fever, nausea, headache, dizziness, chills, muscle cramps, paresthesia, peripheral edema, malaise, respiratory difficulties, flushing and facial swelling. There have been rare reports of thrombocytopenia coincident with SYNVISC (3-injection regimen) injection.

Hypersensitivity reactions including anaphylactic reaction, anaphylactoid reaction, anaphylactic shock and angioedema have been reported.

Ingredients

Ingredients

  • Hylan polymers (hylan A + hylan B) 48 mg
  • Sodium chloride 51 mg
  • Disodium hydrogen phosphate 0.96 mg
  • Sodium dihydrogen phosphate monohydrate 0.24 mg
  • Water for injection q.s. to 6.0 mL

Reviews

There are no reviews yet

Only logged in customers who have purchased this product may leave a review.

You May Also Like This

-